These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2369682

  • 1. The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children.
    Emminger W, Emminger-Schmidmeier W, Höcker P, Gerhartl C, Kundi M, Gadner H.
    Bone Marrow Transplant; 1990 Jun; 5(6):419-24. PubMed ID: 2369682
    [Abstract] [Full Text] [Related]

  • 2. The median rise of leucocytes predicts the optimal days for leukapheresis in children.
    Emminger W, Emminger-Schmidmeier W, Höcker P, Kundi M, Peters C, Gadner H.
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():28-9. PubMed ID: 1969304
    [Abstract] [Full Text] [Related]

  • 3. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR.
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [Abstract] [Full Text] [Related]

  • 4. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [Abstract] [Full Text] [Related]

  • 5. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B, Fraipont V, Baudoux E, Fassotte MF, Hermanne JP, Jérusalem G, Bours V, Bosquée L, Schaaf-Lafontaine N, Paulus JM, Sondag D, Fillet G, Beguin Y.
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [Abstract] [Full Text] [Related]

  • 6. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA, Garcia-Sanchez F, Lillo R, Vicent MG, Vicario JL, Madero L.
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A, Offidani M, Montanari M, Ciniero L, Cantori I, Ombrosi L, Masia CM, Centurioni R, Mancini S, Brunori M, Leoni P.
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [Abstract] [Full Text] [Related]

  • 8. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y, Takaue Y, Watanabe T, Saito S, Abe T, Hirao A, Sato J, Ninomiya T, Suzue T, Koyama T.
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [Abstract] [Full Text] [Related]

  • 9. [Characteristics of autologous peripheral blood stem cells in pediatric patients].
    Bojanić I, Golubić Cepulić B, Nemet D, Rajić L, Batinić D, Labar B.
    Lijec Vjesn; 2006 Jan; 128(1-2):43-8. PubMed ID: 16640227
    [Abstract] [Full Text] [Related]

  • 10. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 11. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE, Lambie K, Sutherland HJ, Benny WB, Dalal B, Currie C, Barnett MJ, Eaves AC, Eaves CJ.
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [Abstract] [Full Text] [Related]

  • 12. [Autologous peripheral stem cell transplantation in children].
    Emminger W, Emminger-Schmidmeier W, Höcker P, Hawliczek R, Peters C, Pawlowsky J, Neuwirth G, Kummer M, Gadner H.
    Klin Padiatr; 1989 Mar; 201(4):299-303. PubMed ID: 2570882
    [Abstract] [Full Text] [Related]

  • 13. Large-volume leukapheresis for peripheral blood progenitor cell collection in low body weight pediatric patients: a single center experience.
    Cecyn KZ, Seber A, Ginani VC, Gonçalves AV, Caram EM, Oguro T, Oliveira OM, Carvalho MM, Bordin JO.
    Transfus Apher Sci; 2005 Jun; 32(3):269-74. PubMed ID: 15908275
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, Abe T, Kawano Y, Kagami S, Takaue Y.
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [Abstract] [Full Text] [Related]

  • 15. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 16. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
    Kwekkeboom J, Buurman DE, Ploemacher RE, Baars JW, Loos HA, Slaper-Cortenbach IC.
    Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
    [Abstract] [Full Text] [Related]

  • 17. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg).
    Kröger N, Zeller W, Hassan HT, Krüger W, Gutensohn K, Löliger C, Zander AR.
    Bone Marrow Transplant; 1999 Jan; 23(2):125-9. PubMed ID: 10197796
    [Abstract] [Full Text] [Related]

  • 18. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 20. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
    Kohno A, Takeyama K, Narabayashi M, Okamoto R, Adachi I, Tobinai K, Shimoyama M.
    Bone Marrow Transplant; 1995 Jan; 15(1):49-54. PubMed ID: 7538002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.